RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque: an OCT-IVUS Imaging Substudy (RESTORE Imaging)
Sponsor: Harbin Medical University
This NA trial investigates Acute Coronary Syndrome (ACS) and is currently actively recruiting participants. Harbin Medical University leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Harbin Medical University
- Shanghai Shenqi Medical Technology Co., Ltd
For direct contact, visit the study record on ClinicalTrials.gov .